tykhr
sign in
free sign up
Catabasis Pharmaceuticals Inc
Biotechnology
Healthcare
CATB
3.73M shares
NASDAQ US
traded
28 Sep 2021
open
9.32
52 week high
13.56
high
9.44
52 week low
1.32
low
8.98
growth
43.79%
previous Close
9.53
P/E ratio
-2
market cap
110M
div yield
0
usd
Jun 2021
qoq
revenue
net incoming
-7.47M
95.61 %
eps
-5.34
88.29 %
eps surprise
-193.41 %
net profit margin
-746600000 %
operating incoming
-7.49M
-36.78 %
net change in cash
-7.40M
-106.07 %
cash on hand
140M
-5.04 %
cost of revenue
top